Open Orphan Limited is a niche CRO pharmaceutical services group that specializes in testing vaccines and antivirals through human challenge clinical trials. It is a world leader in this area and operates from Europe's only 24-bedroom quarantine clinic and specializes in virology and immunology laboratory services to aid respiratory drug, antiviral, and vaccine research and development. The company prides itself on its reliable laboratory analysis, supported by scientific expertise and robust quality processes to guarantee submission-ready data. As the demand for vaccines and antivirals increases, Open Orphan's unique services and expertise are set to grow in demand.